The Company is a Korea-based company principally engaged in researching and developing pharmaceuticals. The Company's products mainly consist of BCD600, BCD700 and BCD800, BCD100 humira, BCD200 cosmeceutical and BCD300 lusentis. BCD500 avastin The Company distributes its products within domestic market and to overseas markets including China and the United Kingdom. The Company was founded on October 28, 2009. and its shares are listed on KOREA NEW EXCHANGE(KONEX) on November 05, 2015.
Headquarters
660,Daewangpangyo-Ro, Bundang-Gu
Seongnam; Gyeonggi;
Contact Details: Purchase the Pharma Research Bio Co. Ltd. report to view the information.
Website: http://www.biocnd.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service